Supplement Scholar
Vitamin

Methylcobalamin (B12)

Buy on Amazon ↗

Affiliate link: we may earn a commission at no extra cost to you. Disclosures

Methylcobalamin (B12). Active methyl-form of B12 — directly usable in the methylation cycle.

How it works. Donates methyl group to homocysteine via methionine synthase; no liver conversion needed.

What the research supports. 2 graded claims. Strongest: Repletes B12 in deficiency (strong).

How much to take. Typical dose: 500–1000 mcg sublingual. Morning.

Side effects and interactions. 1 medication interaction listed. Serious: Discontinue and seek medical advice if symptoms are severe, persistent, or include difficulty breathing.

Stacking. Pairs well with Omega-3 (EPA/DHA), Alpha-GPC or CDP-choline.

Common forms. Available as Capsule or softgel, Sublingual tablet or liquid, Methylated active form for sensitive individuals, Multivitamin matrix.

Key studies. 9 studies cited. The strongest are listed with links to PubMed.

Community. Experiences from people who have tried Methylcobalamin (B12). Anecdotes are not medical advice.

Methylcobalamin (B12). Active methyl-form of B12 — directly usable in the methylation cycle.

Molecular structureC63H91CoN13O14P · 1344.4 g/mol

What it is

Active methyl-form of B12 — directly usable in the methylation cycle.

Food sources

Whole-food sources (animal products for fat-soluble and B-complex vitamins; produce for water-soluble vitamins)Fortified foods (cereals, dairy, plant milks, nutritional yeast)Multivitamins or stand-alone supplements in synthetic or food-derived form

Goals

Energy ProductionBrain & CognitiveMood & Anxiety

How it works

Donates methyl group to homocysteine via methionine synthase; no liver conversion needed.

Pathways

  • Methionine synthase
  • Methylation cycle

Effects

  • +Repletes B12 in deficiency supports
  • +Possible benefit in diabetic neuropathy supports

What the research supports

Repletes B12 in deficiencystrong
Possible benefit in diabetic neuropathylimited

Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.

Typical dose
500–1000 mcg sublingual
TimingMorning
With foodWith a meal containing fat for fat-soluble compounds; otherwise either.
Best formMost evidence is based on the capsule or softgel form.
Shop Methylcobalamin (B12) on Amazon ↗

As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.

Side effects & interactions

Common side effects

  • Methylcobalamin (B12) is generally well-tolerated at evidence-based doses
  • Mild GI discomfort (nausea, loose stools, or bloating) possible at higher intakes
  • Headache or transient fatigue reported by a small fraction of users

Serious

  • Discontinue and seek medical advice if symptoms are severe, persistent, or include difficulty breathing

Medication interactions

Prescription medications (general)minor

Always disclose Methylcobalamin (B12) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.

Check any supplement–medication combination with your pharmacist before starting.

Combines with

Pairs well

  • Omega-3 (EPA/DHA)Membrane fluidity and neuronal signaling support.
  • Alpha-GPC or CDP-cholineProvides choline substrate for acetylcholine synthesis.

Common forms

  • Capsule or softgel
  • Sublingual tablet or liquid
  • Methylated active form for sensitive individuals
  • Multivitamin matrix

Key studies

9 studies cited in total.

PubMed: Methylcobalamin (B12) — Repletes B12 in deficiency ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Methylcobalamin (B12) and "Repletes B12 in deficiency". Filter by RCT, meta-analysis, or year on the results page.

PubMed: Methylcobalamin (B12) — Possible benefit in diabetic neuropathy ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Methylcobalamin (B12) and "Possible benefit in diabetic neuropathy". Filter by RCT, meta-analysis, or year on the results page.

PubMed: Methylcobalamin (B12) — randomized controlled trial ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Methylcobalamin (B12) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

Discussion

Loading discussion…